The impact of low-molecular-weight heparin prophylaxis on mortality in acutely ill medical patients: the LIFENOX study

被引：0
|
作者：
Kakkar, A. [1 ,2 ]
Cimminiello, C. [3 ]
Goldhaber, S. Z. [4 ]
Parakh, R. [5 ]
Wang, C. [6 ]
Bergmann, J-F
机构：
[1] Thrombosis Res Inst, London SW3 6LR, England
[2] UCL, London, England
[3] Osped Civile Vimercate, Unita Operat Med 2, Vimercate, Italy
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[5] Medanta Med, Gurgaon, Haryana, India
[6] Minist Hlth, Beijing Hosp, Beijing Inst Resp Med, Beijing, Peoples R China
[7] Univ Paris Diderot, Hop Lariboisiere, AP HP, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients
    Kakkar, Ajay K.
    Cimminiello, Claudio
    Goldhaber, Samuel Z.
    Parakh, Rajiv
    Wang, Chen
    Bergmann, Jean-Francois
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26): : 2463 - 2472
  • [2] Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients
    McGarry, LJ
    Thompson, D
    Weinstein, MC
    Goldhaber, SZ
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (09): : 632 - 642
  • [3] Mortality reduction with low molecular weight heparin thromboprophylaxis in acutely ill medical patients: The MEDENOX trial.
    Desjardins, L
    Cohen, AT
    Eldor, A
    Janbon, C
    Olsson, CG
    Samama, MM
    Turpie, AGG
    Weisslinger, N
    BLOOD, 1999, 94 (10) : 31A - 31A
  • [4] Prescription of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients
    Ambrosi, P
    Calise, G
    Villani, P
    Luccioni, R
    Bouvenot, G
    PRESSE MEDICALE, 2000, 29 (26): : 1447 - 1450
  • [5] Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients
    du Plessis, J. A.
    van Blydenstein, S. A.
    Wong, M.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (03): : 235 - 242
  • [6] Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients
    Rothberg, Michael B.
    Pekow, Penelope S.
    Lahti, Maureen
    Lindenauer, Peter K.
    JOURNAL OF HOSPITAL MEDICINE, 2012, 7 (06) : 457 - 463
  • [7] Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?
    Minze, Molly G.
    Kwee, Yu-Yu
    Hall, Ronald G., II
    JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (02) : 75 - 80
  • [8] Low-molecular-weight heparin therapy and mortality
    Valentine, KA
    Hull, RD
    Pineo, GF
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (02): : 173 - 178
  • [9] Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin
    Turpie, AGG
    Norris, TM
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (01) : 3 - 12
  • [10] Thromboprophylaxis With Low-Molecular-Weight Heparin in Medical Patients With Cancer
    Lyman, Gary H.
    CANCER, 2009, 115 (24) : 5637 - 5650
12345